H

HiberCell

45 employees

HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Medical

Date founded

2019

Funding rounds raised

Total raised

$67M

from 11 investors over 11 rounds

H

HiberCell raised $30M on May 19, 2021

Investors: Hercules Capital, Inc.

H

HiberCell raised $67M on May 19, 2021

Investors: ARCH Venture Partners, Magnetic Ventures, Monashee Investment Management LLC and Bristol-Myers Squibb, UK

H

HiberCell raised $61M on February 7, 2019

Investors: Life Sciences Fund Amsterdam, 6 Dimensions Capital, ARCH Venture Partners, Magnetic Ventures, Celgene and Hillhouse Capital Management

FAQ